Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III open-label L-arginine for acute stroke-like episodes in MELAS
jRCT2091220023Phase 3Completed
- Sponsor
- Kurume University
- Start
- Nov 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of arginine in mitochondrial encephalomyopathies and stroke-like episode (SLE), sponsored by Kurume University. Primary endpoints: headache and vomit. Started Nov 2008; status: completed.
02
Drugs
arginine
03
Conditions
mitochondrial encephalomyopathiesstroke-like episode (SLE)
Beyond the preview
Go deeper on jRCT2091220023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220023.